Oracle Investment Management’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Oracle Investment Management’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-463,998	Closed	-$1.34M	–	32
2022 Q2	$1.34M	Sell	463,998 -40,604	-8%	-$143K	0.41%	17
2022 Q1	$3.16M	Sell	504,602 -154,589	-23%	-$970K	0.63%	15
2021 Q4	$7.34M	Sell	659,191 -40,809	-6%	-$566K	1.04%	14
2021 Q3	$11.4M	Buy	700,000 +21,300	+3%	+$381K	1.42%	12
2021 Q2	$12.6M	Buy	678,700 +133,340	+24%	+$2.56M	1.73%	11
2021 Q1	$8.22M	Buy	+545,360	New	+$11.9M	1.23%	14

Other funds holding CDAK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Oracle Investment Management's CDAK Position: Q3 2022 in Review

Oracle Investment Management sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q3 2022, closing a stake of 463,998 shares — an estimated $1.34M sold.

Oracle Investment Management first reported a position in CDAK in Q1 2021 and held it in 6 quarters. The position peaked at $12.6M in Q2 2021. 48 funds tracked by Wall St. Rank hold CDAK as of Q3 2022.

Oracle Investment Management reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Oracle Investment Management sold 463,998 Codiak BioSciences, Inc. Common Stock shares in Q3 2022, an estimated $1.34M.
Oracle Investment Management first reported a position in Codiak BioSciences, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
Oracle Investment Management's Codiak BioSciences, Inc. Common Stock position peaked at $12.6M in Q2 2021.
48 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q3 2022.

Based on Oracle Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.